Beta Bionics Q3 2026 Results: Net Loss of $24.4M, Loss Widens
Beta Bionics, Inc. reported net sales of $95.1 million for the nine months ended September 30, 2026, a significant increase from $68.1 million in the prior year period. Despite higher gross profits, the company's net loss widened to $69.7 million for the first nine months of 2026 due to increased operating expenses in sales, marketing, and R&D.
- Key figure
- Net loss $24.4M